The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Mar 2014 09:03

Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation.Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral.British Land: Jefferies downgrades to hold with a target price of 707p.Brooks Macdonald Group: Canaccord Genuity increases target price from 1620p to 1780p, but downgrades from buy to hold.Brown (N) Group: UBS lowers target price from 565p to 535p and downgrades from neutral to sell.Cape: Canaccord Genuity ups target price from 300p to 360p maintaining a buy recommendation.Close Brothers Group: Berenberg raises target price from 1330p to 1640p and maintains a buy recommendation. JP Morgan increases target price from 1357p to 1480p and stays with its overweight rating. UBS raises target price from 1340p to 1420p maintaining a neutral rating.Countrywide: Goldman Sachs ups target price from 748p to 764p, while downgrading to neutral.Craneware: Investec raises target price from 615p to 645p keeping a buy recommendation.Crest Nicholson Holdings: Goldman Sachs shifts target price from 525p to 530p and upgrades to strong buy.esure Group: Deutsche Bank moves target price from 300p to 313p and keeps a buy recommendation. Citi shifts target price from 291p to 294p retaining a buy recommendation. Canaccord Genuity lowers target price from 305p to 295p maintaining its buy recommendation.Fenner: Jefferies lowers target price from 505p to 490p, while staying with its buy recommendation. Espirito Santo cuts target price from 410p to 400p and retains its neutral rating. UBS cuts target price from 500p to 480p leaving its buy recommendation unaltered.Go-Ahead Group: Deutsche Bank increases target price from 1640p to 2100p, while downgrading to hold. RBC Capital raises target price from 1800p to 2300p keeping its neutral rating.Hangar8: Westhouse Securities takes target price from 270p to 310p, but downgrades to add.Hikma Pharmaceuticals: Panmure Gordon ups target price from 1375p to 1400p, while downgrading from buy to hold.Hummingbird Resources: Cantor Fitzgerald moves target price from 68p to 80p leaving its buy recommendation unchanged.Hunting: Investec ups target price from 830p to 890p, but downgrades from buy to hold.IFG Group: N+1 Singer upgrades to buy with a target price of 150p.IMI: RBC Capital cuts target price from 1600p to 1550p and retains an outperform rating. Espirito Santo raises target price from 1530p to 1650p and upgrades to buy.Inchcape: Deutsche Bank ups target price from 655p to 685p and reiterates its hold recommendation. Nomura takes target price from 580p to 600p and maintains its neutral rating.Inmarsat: Jefferies moves target price from 790p to 800p and retains a buy recommendation.International Consolidated Airlines Group: Liberum Capital takes target price from 450p to 550p and keeps a buy recommendation.Kazakhmys: UBS raises target price from 210p to 300p and maintains a neutral rating.Land Securities: Jefferies downgrades to hold with a target price of 1112p.Merlin Entertainment: JP Morgan moves target price from 415p to 430p and maintains an overweight rating.Modern Water: Numis cuts target price from 77p to 62p, while its buy recommendation remains unchanged.Morgan Advanced Materials: Espirito Santo raises target price from 280p to 320p and retains a neutral rating.Persimmon: Goldman Sachs cuts target price from 1892p to 1840p and downgrades from strong buy to buy.Phoenix IT: Panmure Gordon lowers target price from 144p to 136p, while upgrading from hold to buy.Plethora Solutions: Daniel Stewart moves shifts target price from 18.9p to 25.6p and keeps a buy recommendation.Premier Farnell: UBS lowers target price from 240p to 235p and stays with its neutral rating.Redrow: Goldman Sachs raises target price from 341p to 423p upgrading to buy.Rentokil Initial: Credit Suisse ups target price from 95p to 125p and keeps a neutral rating.Rightmove: Goldman Sachs reduces target price from 4360p to 3607p and downgrades from strong buy to buy.Rockhopper Exploration: Canaccord Genuity reduces target price from 345p to 265p, but stays with its buy recommendation.Rotork: Espirito Santo increases target price from 2500p to 2600p and stays with its neutral rating.Servelec Group: Investec raises target price from 284p to 310p and maintains its buy recommendation.Spirax-Sarco Engineering: Espirito Santo raises target price from 3000p to 3200p and reiterates a neutral rating.Travis Perkins: Berenberg cuts target price from 1880p to 1800p and retains a hold recommendation.Tyman: Numis raises target price from 285p to 320p reiterating an add rating.WEIR Group: Espirito Santo raises target price from 2600p to 2800p and maintains a buy recommendation.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.